NETRF Awards Eleven Research Grants to Study Neuroendocrine Cancer
The Neuroendocrine Tumor Research Foundation (NETRF) announced in January 2024 its newest neuroendocrine tumor (NET) research grant recipients. The eleven investigators receiving awards are studying the most promising scientific approaches to understanding and...
Neuroendocrine Tumors in Sicily: The Patient at the Centre of a Multidisciplinary Approach and a Dedicated Diagnostic and Therapeutic Pathway
An important meeting was held on 14 December 2023 at the Order of Surgeons and Dentists of the province of Palermo. NET Italy participated, represented by Luciano Licciardello, to bring the point of view of patients and their problems, i.e. from the preliminary phases...
New INCA Research Committee Chair
Meredith Cummins, CEO of NeuroEndocrine Cancer Australia, is the new INCA Research Committee Chair. She stepped up to this role after active contribution to the INCA Research Committee work in 2023 with her extensive experience in patient advocacy in Australia. She...
Recording of the Pheo Para Alliance Webinar on SDHB-related Paraganglioma Is Now Available
Watch this recorded Pheo Para Alliance webinar featuring Dr. Ali Alzahrani from King Faisal Specialist Hospital & Research Centre in Riyadh, Saudi Arabia who presents information on the SDHB genetic mutation which increases the likelihood of developing...
NETRF Research Symposium Sparks Research Excitement in Boston
NETRF’s 2023 Margie and Robert E Petersen Neuroendocrine Tumor Research Symposium brought together a hundred of the world’s foremost neuroendocrine cancer scientists in Boston. The 16th annual Symposium, held from November 15-17, 2023, showcased the latest...
INCA is a non-profit 501(c)3 organization incorporated in 2013.
